[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-379202-105":59,"doc-detail-379202-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","figo-staging-update-figo-staging-of-endometrial-cancer-2023","FIGO Staging Update - FIGO staging of endometrial cancer - 2023","","Introduction: Advances in the pathologic and molecular understanding of endometrial cancer since the 2009 FIGO update have expanded outcome and biological behavior knowledge across histologic types. Molecular and genetic discoveries, accelerated by TCGA, clarify distinct tumor biology and prognostic differences. The new staging system aims to define prognostic groups more precisely and create substages guiding appropriate surgical, radiation, and systemic therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/figo-staging-update-figo-staging-of-endometrial-cancer-2023/379202/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/figo-staging-update-figo-staging-of-endometrial-cancer-2023/379202.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-24",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was the FIGO staging system for endometrial cancer updated in 2023?","Question",{"text":112,"@type":113},"The article states that many advances in pathologic and molecular features have occurred since the 2009 update, with more outcome and biological behavior data now available.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What committee and process were used to develop the new staging substages?",{"text":117,"@type":113},"The FIGO Women’s Cancer Committee appointed an Endometrial Cancer Staging Subcommittee in October 2021, which reviewed new and established evidence and identified improvement opportunities across four stages.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the overall goal of the 2023 staging system?",{"text":121,"@type":113},"It is intended to better define prognostic groups and create substages that indicate more appropriate surgical, radiation, and systemic therapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},379202,1790742569,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","J Gynecol Oncol. 2023 Sep;34(5):e85 [https://doi.org/10.3802/jgo.2023.34.e85](https://doi.org/10.3802/jgo.2023.34.e85)[ ](https://doi.org/10.3802/jgo.2023.34.e85)pISSN 2005-0380·eISSN 2005-0399  \nFIGO Staging Update  \nPublished online: Aug 8, 2023  \nCorrespondence to  \nJonathan S. Berek  \nStanford University School of Medicine, Stanford Women’s Cancer Center, Stanford Cancer Institute, Stanford, CA, USA.  \nEmail: [jberek@stanford.edu](jberek@stanford.edu)  \n© 2023. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([https://](https://)[ ](https://)[creativecommons.org/licenses/by-nc/4.0/](creativecommons.org/licenses/by-nc/4.0/)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nORCID iDs  \nJonathan S. Berek  [https://orcid.org/0000-0002-8734-1961](https://orcid.org/0000-0002-8734-1961)[ ](https://orcid.org/0000-0002-8734-1961)Xavier Matias-Guiu  [https://orcid.org/0000-0002-7201-6605](https://orcid.org/0000-0002-7201-6605)[ ](https://orcid.org/0000-0002-7201-6605)Carien Creutzberg  [https://orcid.org/0000-0002-7008-4321](https://orcid.org/0000-0002-7008-4321)[ ](https://orcid.org/0000-0002-7008-4321)Christina Fotopoulou  [https://orcid.org/0000-0001-6375-9645](https://orcid.org/0000-0001-6375-9645)[ ](https://orcid.org/0000-0001-6375-9645)David Gaffney  [https://orcid.org/0000-0002-5752-1611](https://orcid.org/0000-0002-5752-1611)[ ](https://orcid.org/0000-0002-5752-1611)Sean Kehoe  [https://orcid.org/0000-0003-3830-9532](https://orcid.org/0000-0003-3830-9532)[ ](https://orcid.org/0000-0003-3830-9532)Kristina Lindemann  [https://orcid.org/0000-0002-2162-0175](https://orcid.org/0000-0002-2162-0175)[ ](https://orcid.org/0000-0002-2162-0175)David Mutch  [https://orcid.org/0000-0002-6921-1581](https://orcid.org/0000-0002-6921-1581)[ ](https://orcid.org/0000-0002-6921-1581)Nicole Concin  [https://orcid.org/0000-0002-9795-2643](https://orcid.org/0000-0002-9795-2643)  \nFIGO staging of endometrial cancer: 2023  \nJonathan S. Berek ,1 Xavier Matias-Guiu ,2 Carien Creutzberg ,3  \nChristina Fotopoulou ,4 David Gaffney ,5 Sean Kehoe ,6 Kristina Lindemann ,7 David Mutch ,8 Nicole Concin ,9,10 Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee  \n1Stanford University School of Medicine, Stanford Women’s Cancer Center, Stanford Cancer Institute, Stanford, CA, USA  \n2Department of Pathology, Hospital U de Bellvitge and Hospital U Arnau de Vilanova, Universities of Lleida and Barcelona, Institut de Recerca Biomèdica de Lleida, Instituto de Investigación Biomédica de Bellvitge, Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain  \n3Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands 4Gynaecological Oncology, Department of Surgery and Cancer, Imperial College London, London, UK 5Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA  \n6Oxford Gynaecological Cancer Centre, Churchill Hospital, Oxford, UK  \n7Department of Gynaecological Cancer, Oslo University Hospital, Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway  \n8Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO, USA 9Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria 10Kliniken Essen-Mitte, Essen, Germany  \nABSTRACT  \nIntroduction: Many advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biological behavior data are now available regarding the several histological types. Molecular and genetic findings have accelerated since the publication of The Cancer Genome Atlas ","cbCainHo1uF9FpP9","https://ap.wps.com/l/cbCainHo1uF9FpP9","pdf",3790107,18,"English","# FIGO staging update\n## Introduction\n## Methods\n## Results\n## Conflict of Interest","[{\"question\":\"Why was the FIGO staging system for endometrial cancer updated in 2023?\",\"answer\":\"The article states that many advances in pathologic and molecular features have occurred since the 2009 update, with more outcome and biological behavior data now available.\"},{\"question\":\"What committee and process were used to develop the new staging substages?\",\"answer\":\"The FIGO Women’s Cancer Committee appointed an Endometrial Cancer Staging Subcommittee in October 2021, which reviewed new and established evidence and identified improvement opportunities across four stages.\"},{\"question\":\"What is the overall goal of the 2023 staging system?\",\"answer\":\"It is intended to better define prognostic groups and create substages that indicate more appropriate surgical, radiation, and systemic therapies.\"}]","FIGO Staging Update - FIGO staging of endometrial cancer - 2023 | PDF",1790234583,45]